Immunochemical heterogeneity of calcitonin in tumor, tumor venous effluent, and peripheral blood of patients with medullary thyroid carcinoma
Heath, H.; Sizemore, G.W.
Journal of Laboratory and Clinical Medicine 93(3): 390-401
1979
ISSN/ISBN: 0022-2143 PMID: 429850 Document Number: 152003
CT -cells but that the relative proportions of immunochemical forms in peripheral blood may vary under different conditions. Acute stimulation of CT secretion, whether by Ca or pentagastrin, increases the ratio of CT monomer to other forms.
Document emailed within 1 workday
Related Documents
Poston, G.J.; Seitz, P.K.; Townsend, C.M.; Alexander, R.W.; Rajaraman, S.; Cooper, C.W.; Thompson, J.C. 1987: Calcitonin gene-related peptide: possible tumor marker for medullary thyroid cancer Surgery 102(6): 1049-1054Yü, Y.; Gao, M.; Zhang, F. 2008: Tumor dormancy of hereditary medullary thyroid carcinoma and RET gene mutations Zhonghua Zhong Liu Za Zhi 30(7): 532-533
Roos, B.A.; Deftos, L.J.; Roberts, G.; Wilson, P.; Bundy, L. 1976: Radioimmunoassay of calcitonin in plasma, normal thyroid, and medullary thyroid carcinoma of the rat Journal of Laboratory and Clinical Medicine 88(2): 173-182
Dambacher, M.A.; Guncaga, J.; Heitz, P.; Haas, H.G. 1973: Calcitonin and the medullary thyroid carcinoma Therapeutische Umschau. Revue Therapeutique 30(10): 740-746
Galán Galán, F.; Garrido Peralta, M. 1982: Calcitonin as a tumor marker. II. Calcitonin in non-thyroid tumors Revista Clinica Espanola 165(2): 73-76
Sesti, A.; Mayerhoefer, M.; Weber, M.; Anner, P.; Wadsak, W.; Dudczak, R.; Haug, A.; Karanikas, G. 2014: Relevance of calcitonin cut-off in the follow-up of medullary thyroid carcinoma for conventional imaging and 18-fluorine-fluorodihydroxyphenylalanine PET Anticancer Research 34(11): 6647-6654
Łacka, K.; Michałek, K.; Majewski, P.ła. 2002: Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse Wiadomosci Lekarskie 55(7-8): 394-403
Miyauchi, A.; Matsuzuka, F.; Kuma, K.; Takai, S.; Maeda, M. 1987: Assessment of surgical treatments of medullary thyroid carcinoma by analysis of serum calcitonin levels Nihon Geka Gakkai Zasshi 88(1): 102-108
Peng, J.; Cai, S.; Leng, X.; Mu, D.; Lu, J.; Chen, H.; Rui, J. 2002: MRNA of MAGE genes as specific markers in detection of tumor cells in the peripheral blood of patients with hepatocellular carcinoma Zhonghua Yu Fang Yi Xue Za Zhi 36(7): 487-490
Mazokopakis, E.E.; Karefilakis, C.M.; Batistakis, A.G.; Syros, P.K.; Kalathas, T.G.; Starakis, I.K. 2010: High serum levels of calcitonin are not pathognomonic of medullary thyroid carcinoma and may indicate polyglandular autoimmune syndrome III Hellenic Journal of Nuclear Medicine 13(1): 67-68
Lin, J.C.; Tsai, C.S.; Wang, W.Y.; Jan, J.S. 2000: Detection of circulating tumor cells in venous blood of nasopharyngeal carcinoma patients by nested reverse transcriptase-polymerase chain reaction Kaohsiung Journal of Medical Sciences 16(1): 1-8
Zeytinoglu, F.N.; Gagel, R.F.; DeLellis, R.A.; Wolfe, H.J.; Tashjian, A.H.; Hammer, R.A.; Leeman, S.E. 1983: Clonal strains of rat medullary thyroid carcinoma cells that produce neurotensin and calcitonin. Functional and morphologic studies Laboratory Investigation; a Journal of Technical Methods and Pathology 49(4): 453-459
Fisher, B.; Saffer, E.A. 1978: Tumor cells cytotoxicity by granulocytes from peripheral blood of tumor-bearing mice Journal of the National Cancer Institute 60(3): 687-691
Miyauchi, A.; Matsuzaka, F.; Kuma, K.; Endo, K.; Ogihara, T.; Maeda, M. 1987: Diagnosis of adrenal medullary diseases in patients with sporadic or hereditary medullary thyroid carcinoma. A report of 37 cases with 8-year follow-up study Nihon Geka Gakkai Zasshi 88(10): 1423-1429
Shang, E.R.; Wu, J.M.; Li, L. 1994: G-banded chromosomes of peripheral blood from both trophoblastic tumor patients and their husbands Zhonghua Fu Chan Ke Za Zhi 29(5): 292-295; 318-319
Miller, F.R.; Heppner, G.H. 1979: Immunologic heterogeneity of tumor cell subpopulations from a single mouse mammary tumor Journal of the National Cancer Institute 63(6): 1457-1463
Dănilă, R.; Popovici, R.; Grigorovici, A.; Ionescu, L.; Timofte, D.; Lefter, L.; Boiculesei, L.V.; Ungureanu, M.C.; Dragomir, C. 2007: The impact of patient and tumor related prognostic factors on survival in non-medullary differentiated thyroid cancer. a study of 125 cases Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 111(4): 940-945
Sato, Y.; Yamamoto, S.; Oya, H.; Nakatsuka, H.; Kobayashi, T.; Takeishi, T.; Hirano, K.; Hara, Y.; Watanabe, T.; Waguri, N.; Suda, T.; Ichida, T.; Aoyagi, Y.; Hatakeyama, K. 2005: Preoperative human-telomerase reverse transcriptase mRNA in peripheral blood and tumor recurrence in living-related liver transplantation for hepatocellular carcinoma Hepato-Gastroenterology 52(65): 1325-1328
Kosareva, A.N.; Iakovleva, M.P. 1972: Detection of tumor cells in the peripheral blood of patients with cancer of the uterine cervix Voprosy Onkologii 18(2): 86-87
Yin, H.L.; Yin, J.; Chen, L.W.; Li, N.; Liu, Z.A.; Hu, Z.B.; Shen, H.B. 2016: Clinical value of classified detection of circulating tumor cells in peripheral blood of NSCLC patients Zhonghua Zhong Liu Za Zhi 38(9): 677-681